Thun MJ, Namboodiri MM, Heath CW: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991, 325 (23): 1593-6.
Article
CAS
PubMed
Google Scholar
Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995, 333 (10): 609-14. 10.1056/NEJM199509073331001.
Article
CAS
PubMed
Google Scholar
García Rodríguez LA, Huerta-Alvarez C: Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology. 2000, 11 (4): 376-81. 10.1097/00001648-200007000-00003.
Article
PubMed
Google Scholar
Pollard M, Luckert PH: Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. J Natl Cancer Inst. 1983, 70 (6): 1103-5.
CAS
PubMed
Google Scholar
Li M, Lotan R, Levin B, Tahara E, Lippman SM, Xu XC: Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev. 2000, 9 (6): 545-9.
CAS
PubMed
Google Scholar
Lehnert T, Deschner EE, Karmali RA, DeCosse JJ: Effect of flurbiprofen and 16,16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue. J Natl Cancer Inst. 1987, 78 (5): 923-9.
CAS
PubMed
Google Scholar
Shibata MA, Hirose M, Masuda A, Kato T, Mutai M, Ito N: Modification of BHA forestomach carcinogenesis in rats: inhibition by diethylmaleate or indomethacin and enhancement by a retinoid. Carcinogenesis. 1993, 14 (7): 1265-9.
Article
CAS
PubMed
Google Scholar
Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y: Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis. 1990, 11 (3): 393-5.
Article
CAS
PubMed
Google Scholar
Lala PK, Al-Mutter N, Orucevic A: Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer. 1997, 73 (3): 371-80. 10.1002/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G.
Article
CAS
PubMed
Google Scholar
Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, Harris RE: Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett. 1998, 122 (1–2): 165-75. 10.1016/S0304-3835(97)00387-X.
Article
CAS
PubMed
Google Scholar
Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC: Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol. 2000, 164: 820-5. 10.1097/00005392-200009010-00056.
Article
CAS
PubMed
Google Scholar
Jalbert G, Castonguay A: Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett. 1992, 66 (1): 21-8.
Article
CAS
PubMed
Google Scholar
Cohen SM, Zenser TV, Murasaki G, Fukushima S, Mattammal MB, Rapp NS, Davis BB: Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res. 1981, 41 (9): 3355-9.
CAS
PubMed
Google Scholar
Sjodahl R: Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. Am J Med. 2001, 110 (1A): 66S-69S. 10.1016/S0002-9343(00)00646-X.
Article
CAS
PubMed
Google Scholar
Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002, 94 (4): 252-66. 10.1093/jnci/94.4.252.
Article
CAS
PubMed
Google Scholar
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993, 85 (4): 307-11.
Article
CAS
PubMed
Google Scholar
Bucher C, Jordan P, Nickeleit V, Torhorst J, Mihatsch MJ: Relative risk of malignant tumors in analgesic abusers: effects of long-term intake of aspirin. Clin Nephrol. 1999, 51: 67-72.
CAS
PubMed
Google Scholar
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.
Article
CAS
PubMed
Google Scholar
Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-101.
Article
CAS
PubMed
Google Scholar
Friedman GD, Ury HK: Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst. 1980, 65 (4): 723-33.
CAS
PubMed
Google Scholar
Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Kato I, Koenig KL, Shore RE: Aspirin and epithelial ovarian cancer. Preventive Medicine. 2001, 33 (6): 682-7. 10.1006/pmed.2001.0945.
Article
CAS
PubMed
Google Scholar
Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O: Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. British Journal of Cancer. 2001, 84 (7): 965-8. 10.1054/bjoc.2001.1702.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anderson KE, Johnson TW, Lazovich D, Folsom AR: Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst. 2002, 94 (15): 1168-71. 10.1093/jnci/94.15.1168.
Article
PubMed
Google Scholar
Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK: Non-steroidal anti-inflammatory drugs and bladder cancer prevention. British Journal of Cancer. 2000, 82 (7): 1364-9. 10.1054/bjoc.1999.1106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S: The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Preventive Medicine. 1999, 29 (2): 72-6. 10.1006/pmed.1999.0518.
Article
CAS
PubMed
Google Scholar
Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S: Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev. 2000, 9 (1): 119-23.
CAS
PubMed
Google Scholar
Cotterchio M, Kreiger N, Sloan M, Steingart A: Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001, 10 (11): 1213-7.
CAS
PubMed
Google Scholar
Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER: Over-the-counter analgesics and risk of ovarian cancer. Lancet. 1998, 351: 104-107. 10.1016/S0140-6736(97)08064-1.
Article
CAS
PubMed
Google Scholar
Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA: Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996, 88 (14): 988-93.
Article
CAS
PubMed
Google Scholar
Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF, Blot WJ: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998, 7 (2): 97-102.
CAS
PubMed
Google Scholar
Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995, 76 (7): 1116-9.
Article
CAS
PubMed
Google Scholar
Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D: Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer. 1996, 68 (3): 295-9. 10.1002/(SICI)1097-0215(19961104)68:3<295::AID-IJC5>3.0.CO;2-X.
Article
CAS
PubMed
Google Scholar
Harris RE, Namboodiri K, Stellman SD, Wynder EL: Breast cancer and NSAID use: Heterogeneity of effect in a case-control study. Prev Med. 1995, 24: 119-20. 10.1006/pmed.1995.1022.
Article
CAS
PubMed
Google Scholar
Harris RE, Namboodiri KK, Farrar WB: Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology. 1996, 7: 203-5.
Article
CAS
PubMed
Google Scholar
Harris RE, Kasbari S, Farrar WB: Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep. 1999, 6 (1): 71-3.
CAS
PubMed
Google Scholar
Langman MJ, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br Med J. 2000, 320 (7250): 1642-6. 10.1136/bmj.320.7250.1642.
Article
CAS
Google Scholar
Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H: Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2001, 10 (8): 903-6.
CAS
PubMed
Google Scholar
Nelson JE, Harris RE: Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. Oncology Reports. 2000, 7 (1): 169-70.
CAS
PubMed
Google Scholar
Norrish AE, Jackson RT, McRae CU: Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer. 1998, 77 (4): 511-5. 10.1002/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.3.CO;2-T.
Article
CAS
PubMed
Google Scholar
Paganini-Hill A, Chao A, Ross RK, Henderson BE: Aspirin use and chronic diseases: A cohort study of the elderly. Br Med J. 1989, 299: 1247-50.
Article
CAS
Google Scholar
Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ: A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc. 2002, 77 (3): 219-25.
Article
PubMed
Google Scholar
Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S: A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000, 9: 933-7.
CAS
PubMed
Google Scholar
Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994, 5 (2): 138-46.
Article
CAS
PubMed
Google Scholar
Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA: Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. British Journal of Cancer. 2000, 83 (1): 112-20. 10.1054/bjoc.2000.1119.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tavani A, Gallus S, La Vecchia C, Conti E, Montella M, Franceschi S: Aspirin and ovarian cancer: an Italian case-control study. Annals of Oncology. 2000, 11 (9): 1171-3. 10.1023/A:1008373616424.
Article
CAS
PubMed
Google Scholar
Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW: Aspirin use and risk of fatal cancer. Cancer Research. 1993, 53 (6): 1322-7.
CAS
PubMed
Google Scholar
Tzonou A, Polychronopoulou A, Hsieh CC, Rebelakos A, Karakatsani A, Trichopoulos D: Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int J Cancer. 1993, 55: 408-10.
Article
CAS
PubMed
Google Scholar
Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V: Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer. 1999, 82 (4): 473-6. 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K.
Article
CAS
PubMed
Google Scholar
Menezes RJ, Huber KR, Mahoney MC, Moysich KB: Regular use of aspirin and pancreatic cancer risk. BMC Public Health. 2002, 2 (1): 18-10.1186/1471-2458-2-18.
Article
PubMed
PubMed Central
Google Scholar
Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE: Aspirin, other NSAIDs, and ovarian cancer risk (United States). Cancer Causes Control. 2002, 13 (6): 535-42. 10.1023/A:1016380917625.
Article
PubMed
Google Scholar
Harris RE, Beebe-Donk J, Schuller HM: Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep. 2002, 9 (4): 693-5.
CAS
PubMed
Google Scholar
Leitzmann MF, Stampfer MJ, Ma J, Chan JM, Colditz GA, Willett WC, Giovannucci E: Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11 (10): 1108-11.
CAS
PubMed
Google Scholar
Irani J, Ravery V, Pariente JL, Chartier-Kastler E, Lechevallier E, Soulie M, Chautard D, Coloby P, Fontaine E, Bladou F, Desgrandchamps F, Haillot O: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol. 2002, 168 (5): 1985-8.
Article
CAS
PubMed
Google Scholar
Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE: Aspirin and lung cancer in women. Br J Cancer. 2002, 87 (1): 49-53. 10.1038/sj.bjc.6600370.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen GM, Bepler G: Regular aspirin use and lung cancer risk. BMC Cancer. 2002, 2 (1): 31-10.1186/1471-2407-2-31.
Article
PubMed
PubMed Central
Google Scholar
Rosenberg L: Nonsteroidal anti-inflammatory drugs and cancer. Prev Med. 1995, 24 (2): 107-9. 10.1006/pmed.1995.1018.
Article
CAS
PubMed
Google Scholar
Habel LA, Zhao W, Stanford JL: Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control. 2002, 13 (5): 427-34. 10.1023/A:1015788502099.
Article
PubMed
Google Scholar
Johnson TW, Anderson KE, Lazovich D, Folsom AR: Association of Aspirin and Nonsteroidal Anti-inflammatory Drug Use with Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11 (12): 1586-91.
CAS
PubMed
Google Scholar
Suleiman UL, Harrison M, Britton A, McPherson K, Bates T: H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study. Eur J Cancer Prev. 2000, 9 (3): 185-91. 10.1097/00008469-200006000-00007.
Article
CAS
PubMed
Google Scholar
Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, Ahmed A, Day NE: A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer. 2000, 83 (1): 127-32. 10.1054/bjoc.2000.1121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meier CR, Schmitz S, Jick H: Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy. 2002, 22 (3): 303-9.
Article
CAS
PubMed
Google Scholar
Neugut AI, Rosenberg DJ, Ahsan H, Jacobson JS, Wahid N, Hagan M, Rahman MI, Khan ZR, Chen L, Pablos-Mendez A, Shea S: Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev. 1998, 7 (10): 869-73.
CAS
PubMed
Google Scholar
McLaughlin JK, Blot WJ, Mehl ES, Fraumeni JF: Relation of analgesic use to renal cancer: population-based findings. Natl Cancer Inst Monogr. 1985, 69: 217-22.
CAS
PubMed
Google Scholar
McCredie M, Ford JM, Stewart JH: Risk factors for cancer of the renal parenchyma. Int J Cancer. 1988, 42 (1): 13-6.
Article
CAS
PubMed
Google Scholar
McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B, Niwa S: International renal-cell cancer study. II. Analgesics. Int J Cancer. 1995, 60 (3): 345-9.
Article
CAS
PubMed
Google Scholar
Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC: Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer. 1999, 81 (3): 542-8. 10.1038/sj.bjc.6690728.
Article
CAS
PubMed
PubMed Central
Google Scholar
Horwitz RI, Feinstein AR: The problem of "protopathic bias" in case-control studies. Am J Med. 1980, 68 (2): 255-8.
Article
CAS
PubMed
Google Scholar
Corley DA, Kerlikowske K, Verma R, Buffler P: Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003, 124 (1): 47-56. 10.1053/gast.2003.50008.
Article
CAS
PubMed
Google Scholar
Anderson WF, Umar A, Viner JL, Hawk ET: The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002, 8 (12): 1035-62.
Article
CAS
PubMed
Google Scholar
Baron JA, Sandler RS: Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med. 2000, 51: 511-23. 10.1146/annurev.med.51.1.511.
Article
CAS
PubMed
Google Scholar
Shaheen NJ, Straus WL, Sandler RS: Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs. Cancer. 2002, 94 (4): 950-63. 10.1002/cncr.10333.abs.
Article
CAS
PubMed
Google Scholar
McLaughlin JK, Lipworth L: Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000, 27 (2): 115-23.
CAS
PubMed
Google Scholar
McCredie M, Stewart JH, Day NE: Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer. 1993, 53 (2): 245-9.
Article
CAS
PubMed
Google Scholar
Feinstein AR, Walter SD, Horwitz RI: An analysis of Berkson's bias in case-control studies. J Chronic Dis. 1986, 39 (7): 495-504.
Article
CAS
PubMed
Google Scholar
Barry MJ: NSAIDs and a lower risk of prostate cancer: causation or confounding?. Mayo Clin Proc. 2002, 77 (3): 217-8.
Article
PubMed
Google Scholar
Poole C, Greenland S: Random-effects meta-analyses are not always conservative. American Journal of Epidemiology. 1999, 150: 469-475.
Article
CAS
PubMed
Google Scholar